The American Academy of Dermatology's (AAD) clinical guidelines are produced for dermatology topics that are of importance to members and their patients in a process that combines a comprehensive review of the best available scientific literature with the clinical judgment of an expert volunteer physician work group. Visit the Guideline Development Process
page to learn more about this process.
Guidelines serve as decision-making and educational aids for clinical practice to support and improve quality dermatologic care, and are used as the framework for:
- Physician Quality Reporting System (PQRS)
- Maintenance of Certification (MOC)
- Reimbursement decisions
- Advocacy efforts
- Public messaging
- Identification of research gaps
Adherence to these guidelines will not ensure successful treatment in every situation. Furthermore, these guidelines should not be interpreted as setting a standard of care, or be deemed inclusive of all proper methods of care nor exclusive of other methods of care reasonably directed to obtaining the same results. The ultimate judgment regarding the propriety of any specific therapy must be made by the physician and the patient in light of all the circumstances presented by the individual patient, and the known variability and biological behavior of the disease. This guideline reflects the best available data at the time the guideline was prepared. The results of future studies may require revisions to the recommendations in this guideline to reflect new data.
AAD Psoriasis app
A new mobile-friendly AAD Web app allows users to access best practices in the complex management of psoriasis and psoriatic arthritis from their mobile devices. It puts the expertise of world-renowned scientists who contributed to the guideline at your fingertips.
The Web app is designed to help users develop the skills required to manage patients with psoriasis and psoriatic arthritis. The content emphasizes decision-making criteria that enable the clinician to individualize therapy based upon disease type, extent, response to previous treatments, quality of life issues, and comorbidities. It enables clinicians to recognize and diagnose challenging cases and formulate appropriate evidence-based treatment for patients.
Clinical recommendations for all available therapies for psoriasis and psoriatic arthritis from the AAD’s clinical guidelines are also included.
View the free Web app on your iPhone, iPad, Android, or other mobile device here.
iPhone and iPad users can create an icon on their devices for easy access to the Web app by following the instructions below:
- Visit www.aad.org/mobile-psoriasis on your iPhone or iPad Safari Web browser.
- Tap on the middle icon with the arrow at the bottom of the Safari screen Web browser.
- Choose the "Add to home screen" icon.
- The Web app icon will be added to your iPhone or iPad home screen.
- Any time you want to access the psoriasis Web app, tap on your new icon.
Have a question or comment
about our guidelines?
Want to get involved and join an upcoming guidelines workgroup
? Have an idea
for a future guideline topic?
Send an email to firstname.lastname@example.org
and let us know!